STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Swedish biotech company Karo Bio (Reuters: KARO.ST) (STO:KARO) today announced that it has updated its portfolio of development projects.
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Swedish biotech company Karo Bio (Reuters: KARO.ST) (STO:KARO) today announced that it has updated its portfolio of development projects.